AN INVESTIGATION FOR PRESCRIPTION DRUGS IN AN ARENA OF VIRAL DISEASES

WHO’s global health expenditure data base explores internationally comparable data on health spending in all WHO Member States. The report incorporates data analytics for various diseases, health expenditure and death toll etc., globally. Viral diseases have always been a burning issue for morbidity and mortality, worldwide. Viral diseases such as Chickenpox, Malaria, Cholera, Bronchitis, Tuberculosis, Meningitis, HIV, Dengue, and Chikungunya etc. have been challenging the medical practitioners, pharmacists, researchers and consumers since decades. Major out of pocket expenditure goes towards the medication of these diseases. For the medication of viral diseases, numbers of pharmaceutical companies are working in the segment of prescription drugs with focusing on different chemical moieties having antiviral activity. The rising expenditures for the prescription of these drugs are a major problem for public and private payers in many countries. In preview of this fact, an investigation is carried out for prescription drugs on the available parameters of price, chemical moieties and pharmaceutical companies in the domain of viral diseases- Chickenpox, Malaria, Bronchitis, and Tuberculosis diseases. Various branded and generic drugs have been studied and analysed for price variability.